<DOC>
	<DOC>NCT02879227</DOC>
	<brief_summary>Phase II study of radiochemotherapy for elderly patients with oesophagus cancer.</brief_summary>
	<brief_title>Radiochemotherapy in Elderly Patients With Oesophagus Cancer</brief_title>
	<detailed_description>Phase II study of radiochemotherapy for elderly patients with oesophagus cancer with Radiotherapy = 50 Gy, 2Gy/f ans chemotherapy with 2 arms arm Cisplatin = Cisplatin 75mg/m2 J1J22 or arm Oxaliplatine = oxaliplatine 85mg/m2 every 2 weeks.</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>patients aged 75 or more with oesophagus cancer (squamous or adenocarcinoma), fit to treat previous radiotherapy no fit to treat</criteria>
	<gender>All</gender>
	<minimum_age>75 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>